Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.1623
-0.0066 (-3.91%)
Jun 22, 2026, 9:32 AM EDT - Market open
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $3.16 million as of June 22, 2026. Its market cap has decreased by -73.63% in one year.
Market Cap
3.16M
Enterprise Value
-1.09M
1-Year Change
-73.63%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $3.16M, a decrease of -98.85%. That is a compound annual growth rate of -61.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 3.16M | -63.11% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galmed Pharmaceuticals | 3.82M |
| Onconetix | 3.48M |
| Virax Biolabs Group | 3.45M |
| Decoy Therapeutics | 3.23M |
| VivoSim Labs | 3.18M |
| Azitra | 2.78M |
| GRI Bio | 2.72M |
| Bone Biologics | 2.62M |